Dose-Intense PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) in Advanced Pancreatic Adenocarcinoma: A Dose-Finding Study

By Reni M.   Cereda S.   Bonetto E.   Vigano M. G.   Passoni P.   Zerbi A.   Balzano G.   Nicoletti R.   Staudacher C.   Carlo V. Di  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 594-598

Informa Healthcare

Access to resources Recommend Favorite

Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

By Reni M.   Cereda S.   Bonetto E.   Viganò M.   Passoni P.   Zerbi A.   Balzano G.   Nicoletti R.   Staudacher C.   Di Carlo V.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 361-367

Springer Publishing Company

Access to resources Recommend Favorite

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

By Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 661-666

Elsevier

Access to resources Recommend Favorite

Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancer

By              

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1204-1210

Spandidos Publications

Access to resources Recommend Favorite

5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: A clinical experience

By Podolsky Lisa   Oh Melissa   Subbarayan Pochi R.   Francheschi Dido   Livingstone Alan   Ardalan Bach  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 602-605

Informa Healthcare

Access to resources Recommend Favorite